Sobre nós Contatos Interações: 118 620
Pesquisa de medicamentos por nome

Tetracon e Disfunção renal

Resultado da verificação da interação do medicamento Tetracon com doença Disfunção renal quanto a segurança no uso em conjunto.

Resultado da verificação:
Tetracon <> Disfunção renal
Relevância: 23.07.2019 Revisor: Shkutko P.M., M.D., in

Na verificação da interação, conforme informações das fontes confiáveis como Drugs.com, Rxlist.com, Webmd.com, Medscape.com, foram identificadas as contra-indicações ou efeitos colaterais que podem prejudicar a saúde ou aumentar efeito negativo ao consumir o medicamento com esta doença concomitante.

Consumidor:

As tetraciclinas (exceto doxiciclina) são eliminados pelo rim em vários extensão. Pacientes com insuficiência renal podem estar em maior risco de tetraciclina associados hepática e/ou toxicidade renal (aumento do BUN com consequente azotemia, hiperfosfatemia e acidose), devido à diminuição de interações de folga. A terapia com tetraciclina deve ser administrado com cautela em doses reduzidas em pacientes com insuficiência renal. Monitorização clínica da função renal e de função hepática é recomendada, e o soro de tetraciclina níveis pode ser necessário durante a terapia prolongada.

Referências
  • Lee P, Crutch ER, Morrison RB, et al "Doxycycline: studies in normal subjects and patients with renal failure." N Z Med J 75 (1972): 355-8
  • Reddy J "Tetracycline antibiotics should be avoided in patients with renal disease." N Z Med J 94 (1981): 396
  • Braden GL, Geheb MA, Shook A, Singer I, Cox M "Demeclocycline-induced natriuresis and renal insufficiency: in vivo and in vitro studies." Am J Kidney Dis 5 (1985): 270-7
  • Heaney D, Eknoyan G "Minocycline and doxycycline kinetics in chronic renal failure." Clin Pharmacol Ther 24 (1978): 233-9
  • "Product Information. Achromycin (tetracycline)." Lederle Laboratories, Wayne, NJ.
  • "Product Information. Vibramycin (doxycycline)." Pfizer US Pharmaceuticals, New York, NY.
  • George CR, Evans RA "Tetracycline toxicity in renal failure." Med J Aust 06/12/71 (1971): 1271-3
  • Miller PD, Linas SL, Schrier RW "Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients." JAMA 243 (1980): 2513-5
  • Jonas M, Cunha BA "Minocycline." Ther Drug Monit 4 (1982): 137-45
  • Carrilho F, Bosch J, Arroyo V, Mas A, Viver J, Rodes J "Renal failure associated with demeclocycline in cirrhosis." Ann Intern Med 87 (1977): 195-7
  • "Product Information. Terramycin (oxytetracycline)." Pfizer US Pharmaceuticals, New York, NY.
  • Saivin S, Houin G "Clinical pharmacokinetics of doxycycline and minocycline." Clin Pharmacokinet 15 (1988): 355-66
  • Roth H, Becker KL, Shalhoub RJ, Katz S "Nephrotoxicity of demethylchlortetracycline hydrochloride. A prospective study." Arch Intern Med 120 (1967): 433-5
  • Whelton A, von Wittenau MS, Twomey TM, et al "Doxycycline pharmacokinetics in the absence of renal function." Kidney Int 5 (1974): 365-71
  • "Product Information. Minocin (minocycline)." Lederle Laboratories, Wayne, NJ.
  • "Product Information. Declomycin (demeclocycline)." Lederle Laboratories, Wayne, NJ.
  • Carney S, Butcher RA, Dawborn JK, Pattison G "Minocycline excretion and distribution in relation to renal function in man." Clin Exp Pharmacol Physiol 1 (1974): 299-308
  • Kirkpatrick R "Demeclocycline and renal insufficiency." JAMA 239 (1978): 616
  • Shils ME "Renal disease and the metabolic effects of tetracycline." Ann Intern Med 58 (1963): 389-408
  • Sklenar I, Spring P, Dettli L "One-dose and multiple-dose kinetics of minocycline in patients with renal disease." Agents Actions 7 (1977): 369-77
  • Whelton A "Tetracyclines in renal insufficiency: resolution of a therapeutic dilemma." Bull N Y Acad Med 54 (1978): 223-36
  • Oster JR, Epstein M "Demeclocycline-induced renal failure." Lancet 1 (1977): 52
  • Houin G, Brunner F, Nebout T, et al "The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man." Br J Clin Pharmacol 16 (1983): 245-52
  • Letteri JM, Miraflor F, Tablante V, Siddiqi S "Doxycycline (vibramycin) in chronic renal failure." Nephron 11 (1973): 318-24
  • Welling PG, Shaw WR, Uman SJ, Tse FL, Craig WA "Pharmacokinetics of minocycline in renal failure." Antimicrob Agents Chemother 8 (1975): 532-7
  • Macdonald H, Kelly RG, Allen ES, et al "Pharmacokinetic studies on minocycline in man." Clin Pharmacol Ther 14 (1973): 852-61
  • Mahon WA, Johnson GE, Endrenyi L, et al "The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function." Scand J Infect Dis 9 (1976): 24-31
  • Brogden RN, Speight TM, Avery GS "Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use." Drugs 9 (1975): 251-91
Tetracon

Nome genérico: tetracycline

Marca comercial: Ala-Tet, Brodspec, Panmycin, Sumycin, Tetracap, Tetracon, Robitet 500, Emtet-500

Sinônimos: não

Interação entre medicamento, comida e estilo de vida
Interações medicamentosas